US Patent Issued to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM on Sept. 23 for "Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy" (Texas Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,420,113, issued on Sept. 23, was assigned to THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy" was invented by Michael D. Story (Dallas), Debabrata Saha (Carrollton, Texas) and Narasimha Kumar Karanam (Dallas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a tumor in a subject, the method comprises applying a tumor treating field to the tumor at a frequency between approximately 50 kHz and approximately 1,000 kHz; and delivering personalized ultra-fractionated adaptive radi...